News flash: The truth never takes a day off

Live event

Congo’s Ebola Death Toll Passes 1,500, Al Jazeera Reports

The Democratic Republic of Congo's Ebola outbreak has claimed more than 1,500 lives as authorities struggle to bring the virus under control in affected areas, according to Al Jazeera. The outbreak involves the Bundibugyo strain, for which there is no vaccine.

Live updates

Loading updates…

Key facts

  • Congo's Ebola death toll has passed 1,500, according to Al Jazeera.
  • The country is struggling to halt the spread of the virus in infected areas.
  • There is currently no vaccine for the Bundibugyo strain of Ebola.
  • The outbreak involves the Bundibugyo strain of the virus.

The death toll from an Ebola outbreak in the Democratic Republic of Congo has passed 1,500 as the country struggles to bring the virus under control, according to Al Jazeera.

The outbreak involves the Bundibugyo strain of the Ebola virus, for which there is currently no vaccine, Al Jazeera reported.

Authorities are continuing to struggle for control in infected areas, the outlet said.

Why it matters

According to Al Jazeera, there is no vaccine for the Bundibugyo strain involved in this outbreak, and the country continues to struggle to halt its spread as the death toll passes 1,500.

Frequently asked questions

How many people have died in Congo's Ebola outbreak?

According to Al Jazeera, the death toll has passed 1,500.

Is there a vaccine for this strain of Ebola?

No. Al Jazeera reports there is still no vaccine for the Bundibugyo strain of the virus.

Which strain of Ebola is involved in the outbreak?

The outbreak involves the Bundibugyo strain of the Ebola virus, according to Al Jazeera.

Timeline

  1. Congo’s Ebola death toll passes 1,500 as it struggles to halt spread

    Al Jazeera: There's still no vaccine for the Bundibugyo strain of the virus as the country struggles for control in infected areas.

Sources

This article was generated with AI assistance, checked against the listed sources, and cleared by an independent AI editorial review.